Skip to main content
Grafa
Technology
Alcon sales top $2.7 billion after 8% increase
Image for illustrative purposes only. Not a real photo.

Alcon sales top $2.7 billion after 8% increase

Share
  • Alcon reported Q2 2026 net sales of $2.78 billion, up 8% reported and 7% at constant currencies.
  • Core diluted EPS increased to $0.84, while GAAP EPS fell to $0.00 following a $402 million pre-tax PowerVision charge.
  • Alcon raised 2026 core EPS growth guidance to 12%–15% and reduced its expected net tariff impact to $40–$90 million.

Alcon (NYSE:ALC) reported second-quarter 2026 net sales of $2.78 billion, up 8% year over year, while core diluted EPS reached $0.84.

Sales rose from $2.58 billion and core EPS increased from $0.76, while core operating margin expanded to 20.6% from 19.1%.

GAAP EPS fell to $0.00 after a $402 million pre-tax PowerVision charge, while Alcon raised core EPS growth guidance to 12%–15%.

Following the announcement, Alcon's share price was up 2.2% at $75.22.

Surgical sales rose 8% to $1.57 billion, led by 26% equipment growth, while Vision Care revenue increased 8% to $1.21 billion.

Alcon returned $538 million to shareholders during the first half and now expects a $40–$90 million full-year tariff impact after an anticipated $60 million U.S. refund.

Frequently asked questions